Jeffrey Walker, MD, has joined Angiotech Pharmaceuticals (Vancouver, British Columbia) as senior vice president, research and development. Walker has more than 14 years' experience at pharmaceutical and medical device companies in developing combination medical devices, drug development and drug delivery technologies, most recently as vice president, advanced technology/new ventures at Medtronic Vascular. Angiotech Pharmaceuticals is a global specialty pharmaceutical and medical device company developing treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury.

Paul Smith has been named vice president, sales and marketing of Axela Biosensors (Toronto). Smith joins Axela having recently held the position of vice president, sales Europe and North America, for Ciphergen Biosystems. Axela Biosensors is commercializing the dotLab System, a biosensor platform that enables researchers to rapidly detect biomarkers in complex media and understand molecular interactions at their benchtop in real-time.

Scott Youngstrom has been named CFO of Enpath Medical (Minneapolis). Youngstrom brings 20 years of financial experience in a variety of medical device companies, most recently as vice president and CFO of Compex Technologies. He replaces James Hartman as the company's CFO. Hartman retired as CEO in January, and with Youngstrom's addition, now will serve solely as chairman of the board. Enpath Medical makes percutaneous delivery systems and stimulation leads technologies.

Kenneth Westbrook has been named president and appointed to the board of directors of flexSCAN (Mission Viejo, California). Westbrook brings more than 25 years of experience to the company, including serving as senior vice president of operations for Tenet Healthcare, chief operating officer for HCA Healthcare's Pacific Division and as the CEO of four California community hospitals. flex-SCAN has developed myWellness360 – a supplemental corporate wellness program that blends comprehensive disease screening with other prevention measures plus online fitness, nutrition and medical records services.

Richard Lussier has been appointed to the newly created position of vice president, sales and field operations for Solexa (Hayward, California). Lussier brings to Solexa over 20 years of industry experience, including 12 years with Applied Biosystems. Solexa is developing the Solexa Genome Analysis System, used to perform analyses including whole genome resequencing, gene expression analysis and small-RNA analysis.

Doug King has been appointed vice president and general manager of Waters Medical Systems (Minneapolis), a subsidiary of Zareba Systems. King replaces Dave Schollman, who retired as general manager effective June 30, after serving in that capacity since 1989. Most recently, King served as CEO of Spineology. Waters Medical Systems makes kidney perfusion devices and whole-blood oximetry products.

No Comments